Dr. Tarasow is an accomplished R&D executive and entrepreneur with more than 24 years of experience in both drug and diagnostic development.  He has built and led successful multidisciplinary teams to develop innovative drug discovery technologies, optimize lead compounds, and scale up and transfer synthetic processes for cGMP production and first in human clinical trials.  In addition, he has developed novel diagnostic platforms and products, and implemented those products in clinical laboratories.

Dr. Tarasow was a founder of Vanquish Oncology, Invenux Pharmaceuticals, and Transverse Medical.  He has also served in executive or leadership roles at HealthTell, Tethys Biosciences, Lawrence Livermore National Laboratory, and NeXstar Pharmaceuticals, as well as on the Scientific Advisory Boards for Systems Oncology and AccelaPure Corporation.

Dr. Tarasow received his PhD in Organic Chemistry from The Scripps Research Institute and his BS in Chemistry from the California Polytechnic State University, San Luis Obispo (Summa Cum Laude).  He has published more than 25 scientific articles and has received 8 issued US patents.